References
- Aberle DR, Adams AM, Berg CD, et al (2011). Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med, 365, 395-409. https://doi.org/10.1056/NEJMoa1102873
- Aksenov AA, Gojova A, Zhao W, et al (2012). Characterization of volatile organic compounds in human leukocyte antigen heterologous expression systems: a cell's “chemical odor fingerprint”. Chembiochem, 13, 1053-9. https://doi.org/10.1002/cbic.201200011
- Albert KJ, Lewis NS, Schauer CL, et al (2000). Cross-reactive chemical sensor arrays. Chem Rev, 100, 2595-626. https://doi.org/10.1021/cr980102w
- Barash O, Peled N, Hirsch FR, Haick H (2009). Sniffing the unique “odor print” of non small cell lung cancer with gold nanoparticles. Small, 5, 2618-24. https://doi.org/10.1002/smll.200900937
- Barash O, Peled N, Tisch U, et al (2012). Classification of lung cancer histology by gold nanoparticle sensors. Nanomedicine, 8, 580-9. https://doi.org/10.1016/j.nano.2011.10.001
- Belinsky SA, Klinge DM, Dekker JD, et al (2005). Gene promoter methylation in plasma and sputum increases with lung cancer risk. Clin Cancer Res, 11, 6505-11. https://doi.org/10.1158/1078-0432.CCR-05-0625
- Boedeker E, Friedel G, Walles T (2012). Sniffer dogs as part of a bimodal bionic research approach to develop a lung cancer screening. Interact Cardiovasc Thorac Surg, 14, 511-5. https://doi.org/10.1093/icvts/ivr070
- Brett GZ (1968). The value of lung cancer detection by six-monthly chest radiographs. Thorax, 23, 414-20. https://doi.org/10.1136/thx.23.4.414
- Brosseau C, Boulic F, Queffelec P (1997). Dielectric and microstructure properties of polymer carbon black composites. J Appl Phys, 81, 882-91. https://doi.org/10.1063/1.364173
- Castro M, Kumar B, Feller JF (2011). Novel e-nose for the discrimination of volatile organic biomarkers with an array of carbon nanotubes (CNT) conductive polymer nanocomposites (CPC) sensors. Sens Actuators B: Chemical, 159, 213-9. https://doi.org/10.1016/j.snb.2011.06.073
- Chen X, Cao MF, Li Y (2005). A study of an electronic nose for detection of lung cancer based on a virtual SAW gas sensors array and imaging recognition method. Meas Sci Technol, 16, 1535-46. https://doi.org/10.1088/0957-0233/16/8/001
- Chow KK, Short M, Zeng H (2012). A comparison of spectroscopic techniques for human breath analysis. Biomedical Spectroscopy Imaging, 1, 339-53.
- Chung-man Ho J, Zheng S, Comhair SA, et al (2001). Differential expression of manganese superoxide dismutase and catalase in lung cancer. Cancer Res, 61, 8578-85.
- D'Amico A, Pennazza G, Santonico M, et al (2010). An investigation on electronic nose diagnosis of lung cancer. Lung Cancer, 68, 170-6. https://doi.org/10.1016/j.lungcan.2009.11.003
- De Wever W, Ceyssens S, Mortelmans L, et al (2007). Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT. Eur Radiol, 17, 23-32. https://doi.org/10.1007/s00330-006-0284-4
- Detterbeck FC, DeCamp MM Jr, Kohman LJ, Silvestri GA (2003). Lung cancer. Invasive staging: the guidelines. Chest, 123, 167-75. https://doi.org/10.1378/chest.123.1_suppl.167S
- Di Natale C, Macagnano A, Martinelli E, et al (2003). Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. Biosens Bioelectron, 18, 1209-18. https://doi.org/10.1016/S0956-5663(03)00086-1
- Doria-Rose VP, Marcus PM (2009). Death certificates provide an adequate source of cause of death information when evaluating lung cancer mortality: An example from the Mayo Lung Project. Lung Cancer, 63, 295-300. https://doi.org/10.1016/j.lungcan.2008.05.019
- Doria-Rose VP, Marcus PM, Szabo E, et al (2009). Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study. Cancer, 115, 5007-17. https://doi.org/10.1002/cncr.24545
- Ehmann R, Boedeker E, Friedrich U, et al (2012). Canine scent detection in the diagnosis of lung cancer: revisiting a puzzling phenomenon. Eur Respir J, 39, 669-76. https://doi.org/10.1183/09031936.00051711
- Ferlay J, Shin HR, Bray F, et al (2010). GLOBOCAN 2008, Cancer incidence and mortality worldwide: IARC CancerBase No. 10. 2010 [Internet]: Lyon, France: International Agency for Research on Cancer.
- Field JK, Smith RA, Aberle DR, et al (2012). International Association for the Study of Lung Cancer Computed Tomography Screening Workshop 2011 report. J Thorac Oncol, 7, 10-9. https://doi.org/10.1097/JTO.0b013e31823c58ab
- Flehinger BJ, Melamed MR, Zaman MB, et al (1984). Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Memorial Sloan-Kettering study. Am Rev Respir Dis, 130, 555-60.
- Fontana RS, Sanderson DR, Taylor WF, et al (1984). Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Mayo Clinic study. Am Rev Respir Dis, 130, 561-5.
- Fontana RS, Sanderson DR, Woolner LB, et al (1986). Lung-Cancer Screening - the Mayo Program. J Occup Med, 28, 746-50. https://doi.org/10.1097/00043764-198608000-00038
- Fossella F, Komaki R, Putnam J (2003). Lung Cancer. MD Anderson Cancer Care Series. New York, NY Springer-Verlag.
- Frost JK, Ball WC Jr, Levin ML, et al (1984). Early lung cancer detection: results of the initial (prevalence) radiologic and cytologic screening in the Johns Hopkins study. Am Rev Respir Dis, 130, 549-54.
- Ghosal R, Kloer P, Lewis KE (2009). A review of novel biological tools used in screening for the early detection of lung cancer. Postgrad Med J, 85, 358-63. https://doi.org/10.1136/pgmj.2008.076307
- Gordon SM, Szidon JP, Krotoszynski BK, et al (1985). Volatile organic compounds in exhaled air from patients with lung cancer. Clin Chem, 31, 1278-82.
- Hakim M, Broza YY, Barash O, et al (2012). Volatile organic compounds of lung cancer and possible biochemical pathways. Chem Rev, 112, 5949-66. https://doi.org/10.1021/cr300174a
- Halliwell B (1996). Antioxidants in human health and disease. Annu Rev Nutr, 16, 33-50. https://doi.org/10.1146/annurev.nu.16.070196.000341
- Hanai Y, Shimono K, Matsumura K, et al (2012). Urinary volatile compounds as biomarkers for lung cancer. Biosci Biotechnol Biochem, 76, 679-84. https://doi.org/10.1271/bbb.110760
- Hardie DG, Hawley SA, Scott JW (2006). AMP-activated protein kinase--development of the energy sensor concept. J Physiol, 574, 7-15. https://doi.org/10.1113/jphysiol.2006.108944
- Hochhegger B, Marchiori EIrion K (2013). MRI in lymph node staging of lung cancer. AJR Am J Roentgenol, 200, 540. https://doi.org/10.2214/AJR.12.9973
- Holty JE, Kuschner WG, Gould MK (2005). Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis. Thorax, 60, 949-55. https://doi.org/10.1136/thx.2005.041525
- Hou C, Dong J, Zhang G, et al (2011). Colorimetric artificial tongue for protein identification. Biosens Bioelectron, 26, 3981-6. https://doi.org/10.1016/j.bios.2010.11.025
- Hou C, Lei J, Huo D (2013). Discrimination of Lung Cancer Related Volatile Organic Compounds with a Colorimetric Sensor Array. Anal Lett, 46, 2048-59. https://doi.org/10.1080/00032719.2013.782550
- Hujala KT, Sipila JI, Grenman R (2001). Mediastinoscopy--its role and value today in the differential diagnosis of mediastinal pathology. Acta Oncol, 40, 79-82. https://doi.org/10.1080/028418601750071109
- Janzen MC, Ponder JB, Bailey DP, et al (2006). Colorimetric sensor arrays for volatile organic compounds. Anal Chem, 78, 3591-600. https://doi.org/10.1021/ac052111s
- Karki S, Yin Yj, Samanai N et al (2013). Breathe analyzer and its importance for the early detection of lung cancer. Sky J Med Med Sci, 1, 7-9.
- Kneepkens CM, Lepage G, Roy CC (1994). The potential of the hydrocarbon breath test as a measure of lipid-peroxidation. Free Radic Biol Med, 17, 127-60. https://doi.org/10.1016/0891-5849(94)90110-4
- Kubik A, Polak J (1986). Lung cancer detection. Results of a randomized prospective study in Czechoslovakia. Cancer, 57, 2427-37. https://doi.org/10.1002/1097-0142(19860615)57:12<2427::AID-CNCR2820571230>3.0.CO;2-M
- Leng S, Do K, Yingling CM, et al (2012). Defining a gene promoter methylation signature in sputum for lung cancer risk assessment. Clin Cancer Res, 18, 3387-95. https://doi.org/10.1158/1078-0432.CCR-11-3049
- Marcus PM, Bergstralh EJ, Fagerstrom RM, et al (2000). Lung cancer mortality in the Mayo Lung Project: impact of extended follow-up. J Natl Cancer Inst, 92, 1308-16. https://doi.org/10.1093/jnci/92.16.1308
- Marnett LJ (2000). Oxyradicals and DNA damage. Carcinogenesis, 21, 361-70. https://doi.org/10.1093/carcin/21.3.361
- Mazzone PJ (2008). Analysis of volatile organic compounds in the exhaled breath for the diagnosis of lung cancer. J Thorac Oncol, 3, 774-80. https://doi.org/10.1097/JTO.0b013e31817c7439
- Mazzone PJ, Hammel J, Dweik R, et al (2007). Diagnosis of lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax, 62, 565-8. https://doi.org/10.1136/thx.2006.072892
- Mazzone PJ, Obuchowski N, Phillips M, et al (2013). Lung cancer screening with computer aided detection chest radiography: design and results of a randomized, controlled trial. PLOS ONE, 8, 59650. https://doi.org/10.1371/journal.pone.0059650
- Mazzone PJ, Wang XF, Xu Y, et al (2012). Exhaled breath analysis with a colorimetric sensor array for the identification and characterization of lung cancer. J Thorac Oncol, 7, 137-42. https://doi.org/10.1097/JTO.0b013e318233d80f
- McCulloch M, Jezierski T, Broffman M, et al (2006). Diagnostic accuracy of canine scent detection in early- and late-stage lung and breast cancers. Integr Cancer Ther, 5, 30-9. https://doi.org/10.1177/1534735405285096
- McWilliams A, Mayo J, MacDonald S, et al (2003). Lung Cancer Screening A Different Paradigm. Am J Respir Crit Care Med, 168, 1167-73. https://doi.org/10.1164/rccm.200301-144OC
- Melamed MR, Flehinger BJ, Zaman MB, et al (1984). Screening for early lung cancer. Results of the Memorial Sloan-Kettering study in New York. Chest, 86, 44-53.
- Miyazu YM, Miyazawa T, Hiyama K, et al (2005). Telomerase expression in noncancerous bronchial epithelia is a possible marker of early development of lung cancer. Cancer Res, 65, 9623-7. https://doi.org/10.1158/0008-5472.CAN-05-0976
- Moser E, McCulloch M (2010). Canine scent detection of human cancers: A review of methods and accuracy. J Vet Behav, 5, 145-52. https://doi.org/10.1016/j.jveb.2010.01.002
- Muro ML, Daws CA, Castellano FN (2008). Microarray pattern recognition based on Pt(II) terpyridyl chloride complexes: vapochromic and vapoluminescent response. Chem Commun, 14, 6134-6.
- Oken MM, Hocking WG, Kvale PA, et al (2011). Screening by Chest Radiograph and Lung Cancer Mortality The Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Trial. JAMA, 306, 1865-73. https://doi.org/10.1001/jama.2011.1591
- Pauling L, Robinson AB, Teranishi R, Cary P (1971). Quantitative analysis of urine vapor and breath by gas-liquid partition chromatography. Proc Natl Acad Sci USA, 68, 2374-6. https://doi.org/10.1073/pnas.68.10.2374
- Peled N, Barash O, Tisch U, et al (2013). Volatile fingerprints of cancer specific genetic mutations. Nanomed Nanotechnol, 9, 758-66. https://doi.org/10.1016/j.nano.2013.01.008
- Peng G, Hakim M, Broza YY, et al (2010). Detection of lung, breast, colorectal, and prostate cancers from exhaled breath using a single array of nanosensors. Br J Cancer, 103, 542-51. https://doi.org/10.1038/sj.bjc.6605810
- Peng G, Tisch U, Adams O, et al (2009). Diagnosing lung cancer in exhaled breath using gold nanoparticles. Nat Nanotechnol, 4, 669-73. https://doi.org/10.1038/nnano.2009.235
- Phillips M, Altorki N, Austin JHM (2007). Prediction of lung cancer using volatile biomarkers in breath. Cancer Biomark, 3, 95-109.
- Phillips M, Cataneo RN, Cummin AR, et al (2003). Detection of lung cancer with volatile markers in the breath. Chest, 123, 2115-23. https://doi.org/10.1378/chest.123.6.2115
- Phillips M, Gleeson K, Hughes JM, et al (1999). Volatile organic compounds in breath as markers of lung cancer: a cross-sectional study. Lancet, 353, 1930-3. https://doi.org/10.1016/S0140-6736(98)07552-7
- Phillips M, Herrera J, Krishnan S, et al (1999). Variation in volatile organic compounds in the breath of normal humans. J Chromatogr B Biomed Sci Appl, 729, 75-88. https://doi.org/10.1016/S0378-4347(99)00127-9
- Poli G, Leonarduzzi G, Biasi F, Chiarpotto E (2004). Oxidative stress and cell signalling. Curr Med Chem, 11, 1163-82. https://doi.org/10.2174/0929867043365323
- Poyton RO, Ball KA, Castello PR (2009). Mitochondrial generation of free radicals and hypoxic signaling. Trends Endocrinol Metab, 20, 332-40. https://doi.org/10.1016/j.tem.2009.04.001
- Pysanenko A, Span.l P, Smith D (2008). A study of sulfur-containing compounds in mouth- and nose-exhaled breath and in the oral cavity using selected ion flow tube mass spectrometry. J Breath Res, 2, 046004. https://doi.org/10.1088/1752-7155/2/4/046004
- Rami Porta R (1999). Surgical exploration of the mediastinum by mediastinoscopy, parasternal mediastinotomy and remediastinoscopy: indications, technique and complications. Ann Ital Chir, 70, 867-72.
- Ramshankar V, Krishnamurthy A (2013). Lung cancer detection by screening - presenting circulating miRNAs as a promising next generation biomarker breakthrough. Asian Pac J Cancer Prev, 14, 2167-72. https://doi.org/10.7314/APJCP.2013.14.4.2167
- Roos PH, Tschirbs S, Pfeifer F, et al (2004). Risk potentials for humans of original and remediated PAH-contaminated soils: application of biomarkers of effect. Toxicology, 205, 181-94. https://doi.org/10.1016/j.tox.2004.06.050
- Santonico M, Lucantoni G, Pennazza G, et al (2012). In situ detection Of lung cancer volatile fingerprints using bronchoscopic air-sampling. Lung Cancer, 77, 46-50. https://doi.org/10.1016/j.lungcan.2011.12.010
- Sauerbrey G (1959). Use of vibrating quartz for thin film weighing and microweighing. Z Phys, 155, 206-22. https://doi.org/10.1007/BF01337937
- Semelka RC, Armao DM, Elias J Jr, Huda W (2007). Imaging strategies to reduce the risk of radiation in CT studies, including selective substitution with MRI. J Magn Reson Imaging, 25, 900-9. https://doi.org/10.1002/jmri.20895
- Smith D, Wang T, Sule-Suso J, et al (2003). Quantification of acetaldehyde released by lung cancer cells in vitro using selected ion flow tube mass spectrometry. Rapid Commun Mass Spectrom, 17, 845-50. https://doi.org/10.1002/rcm.984
- Sozzi G, Conte D, Leon M, et al (2003). Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol, 21, 3902-8. https://doi.org/10.1200/JCO.2003.02.006
- Spiro SG, Navani N (2012). Screening for lung cancer: Is this the way forward? Respirology, 17, 237-46. https://doi.org/10.1111/j.1440-1843.2011.02114.x
- Tanaka K, Akechi T, Okuyama T, et al (2002). Prevalence and screening of dyspnea interfering with daily life activities in ambulatory patients with advanced lung cancer. J Pain Symptom Manage, 23, 484-9. https://doi.org/10.1016/S0885-3924(02)00394-9
- Tanner NT, Mehta H, Silvestri GA (2012). New testing for lung cancer screening. Oncology, 26, 176-82.
- Tisch U, Billan S, Ilouze M (2012). Volatile organic compounds in exhaled breath as biomarkers for the early detection and screening of lung cancer. CML Lung Cancer, 5, 107-17.
- Tockman MS, Mulshine JL (1997). Sputum screening by quantitative microscopy: a new dawn for detection of lung cancer? Mayo Clin Proc, 72, 788-90. https://doi.org/10.1016/S0025-6196(11)63601-X
- Valko M, Rhodes CJ, Moncol J, et al (2006). Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact, 160, 1-40. https://doi.org/10.1016/j.cbi.2005.12.009
- Wang D, Yu K, Wang Y (2012). A hybrid electronic noses'system based on mos-saw detection units intended for lung cancer diagnosis. J Innov Opt Health Sci, 5, 1150006. https://doi.org/10.1142/S1793545811500064
- Wang Y, Gu J, Roth JA, et al (2013). Pathway-based serum microRNA profiling and survival in patients with advanced non-small cell lung cancer. Cancer Res, 73, 4801-9. https://doi.org/10.1158/0008-5472.CAN-12-3273
- Williams H, Pembroke A (1989). Sniffer dogs in the melanoma clinic? Lancet, 1, 734.
- Wilson A D, Baietto M (2009). Applications and advances in electronic-nose technologies. Sensors (Basel), 9, 5099-148. https://doi.org/10.3390/s90705099
- Wohltjen H (1984). Mechanism of operation and design considerations for surface acoustic-wave device vapor sensors. Sens Actuators, 5, 307-25. https://doi.org/10.1016/0250-6874(84)85014-3
- Xiang D, Zhang B, Doll D, et al (2013). Lung cancer screening: from imaging to biomarker. Biomarker Res, 1, 1-10. https://doi.org/10.1186/2050-7771-1-1
- Yang SY, Xiao XY, Zhang WG, et al (2005). Application of serum SELDI proteomic patterns in diagnosis of lung cancer. BMC Cancer, 5, 83. https://doi.org/10.1186/1471-2407-5-83
- Yao Q, Sun JG, Ma H, et al (2014). Monitoring microRNAs using a molecular beacon in CD133+/ CD338+ human lung adenocarcinoma-initiating A549 cells. Asian Pac J Cancer Prev, 15, 161-6. https://doi.org/10.7314/APJCP.2014.15.1.161
- Yu H, Xu L, Cao MF (2003). Detection volatile organic compounds in breath as markers of lung cancer using a novel electronic nose. Proceedings of the IEEE Sensors, 2, 1333-7.
- Zhong D, Guo L, de Aguirre I, et al (2006). LKB1 mutation in large cell carcinoma of the lung. Lung Cancer, 53, 285-94. https://doi.org/10.1016/j.lungcan.2006.05.018
Cited by
- Comparative Assessment of the Diagnostic Value of Transbronchial Lung Biopsy and Bronchoalveolar Lavage Fluid Cytology in Lung Cancer vol.16, pp.1, 2015, https://doi.org/10.7314/APJCP.2015.16.1.201
- Detection of lung cancer with electronic nose and logistic regression analysis vol.13, pp.1, 2018, https://doi.org/10.1088/1752-7163/aae1b8